These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2250574)

  • 1. The effect of serotonergic agents on haloperidol-induced catalepsy.
    Hicks PB
    Life Sci; 1990; 47(18):1609-15. PubMed ID: 2250574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic involvement in haloperidol-induced catalepsy.
    Neal-Beliveau BS; Joyce JN; Lucki I
    J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central 5-HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role.
    De Deurwaerdère P; Cervo L; Stinus L; Spampinato U
    Pharmacol Biochem Behav; 2002 Apr; 71(4):627-33. PubMed ID: 11888554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of serotonergic agents on adenosine A2 receptor mediated catalepsy in mice.
    Mandhane SN; Khisti RT; Chopde CT
    Psychopharmacology (Berl); 1998 May; 137(2):113-9. PubMed ID: 9629997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy.
    Prinssen EP; Colpaert FC; Koek W
    Eur J Pharmacol; 2002 Oct; 453(2-3):217-21. PubMed ID: 12398907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5-HT in globus pallidus on haloperidol-induced catalepsy in rats.
    Wei L; Chen L
    Neurosci Lett; 2009 Apr; 454(1):49-52. PubMed ID: 19429052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
    Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of chlorpromazine-induced catalepsy by the 5-HT-1A ligands pindolol and buspirone in mice.
    Silva SR; Futuro-Neto HA; Pires JG
    Braz J Med Biol Res; 1990; 23(9):869-71. PubMed ID: 2101330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.
    Invernizzi RW; Garavaglia C; Samanin R
    Neuropsychopharmacology; 2003 May; 28(5):872-9. PubMed ID: 12644843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
    Ninan I; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
    Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M
    Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
    Haleem DJ; Shireen E; Haleem MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1323-9. PubMed ID: 15588759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
    Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
    Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cataleptic effect of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice: modulation by serotonergic agents.
    Deshpande LS; Khisti RT; Chopde CT
    Brain Res; 2001 Apr; 898(1):13-26. PubMed ID: 11292445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.
    Reavill C; Kettle A; Holland V; Riley G; Blackburn TP
    Br J Pharmacol; 1999 Feb; 126(3):572-4. PubMed ID: 10188965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic modulation of extrapyramidal motor disorders in mice and rats: role of striatal 5-HT3 and 5-HT6 receptors.
    Ohno Y; Imaki J; Mae Y; Takahashi T; Tatara A
    Neuropharmacology; 2011; 60(2-3):201-8. PubMed ID: 20813116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of presynaptic 5-HT
    Mombereau C; Arnt J; Mørk A
    Pharmacol Biochem Behav; 2017 Feb; 153():141-146. PubMed ID: 28057524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
    Mignon L; Wolf WA
    Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat.
    Wadenberg ML; Young KA; Richter JT; Hicks PB
    Neuropharmacology; 1999 Jan; 38(1):151-6. PubMed ID: 10193906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.